PedAM
Pediatric Disease Annotations & Medicines
| Disease | pneumonia |
| Phenotype | C0032285|lung inflammation |
| Sentences | 5 |
| PubMedID- 24752301 | Notably, lung inflammation (pneumonitis) is the most severe adverse event reported in human clinical trials of pd-1 mab (topalian et al., 2012). |
| PubMedID- 20399910 | Thus thalidomide proved a promising immunomodulatory agent in acute lung inflammation associated with pneumonia caused by gram negative bacterial infection. |
| PubMedID- 21771345 | Alveolar neutrophil apoptosis has been suggested to help down-regulating lung inflammation in patients with community acquired pneumonia [40]. |
| PubMedID- PMC3504804 | Thalidomide proved a promising immunomodulatory agent with a potential to modulate aggravated innate immune response observed during acute lung inflammation associated with pneumonia or sepsis caused by gram-negative bacterial infection. |
| PubMedID- 23133376 | This model of k. pneumoniae pneumonia is associated with profound lung inflammation [36]–[38]. |
Page: 1